Mon, November 9, 2026
|
CannabisInsightKorea's Cannabis Business & Policy Media

Global

71 articles

Tracked Brazilian Medical Cannabis Channels Generate R$485.4 Million in 12 Months
Global

Tracked Brazilian Medical Cannabis Channels Generate R$485.4 Million in 12 Months

Tracked Brazilian channels generated R$485.4 million over the year ending August 2026, up 15%, while reported prescribing physicians rose 32.3% to 78,075. These consultancy figures do not cover the entire market. They are distinct from individual import authorizations.

2026-11-05

Massachusetts Voters Reject Adult-Use Cannabis Sales Repeal
Global

Massachusetts Voters Reject Adult-Use Cannabis Sales Repeal

Massachusetts voters rejected Question 8 on November 3, preserving adult-use sales. More than 75% opposition was an election-night snapshot, not a verified certified total. This resolves the previously covered ballot qualification event.

2026-11-03

Newly released Nepal Supreme Court verdict directs rules for medical and industrial cannabis
Global

Newly released Nepal Supreme Court verdict directs rules for medical and industrial cannabis

A recently released Nepal Supreme Court verdict directs licensing and supervision for controlled medical, scientific and industrial cannabis. The ruling dates to May 18, 2025, with a three-month deadline from government receipt. The November report does not itself authorize cultivation or recreational use.

2026-11-01

EU Council adopts negotiating position covering the whole hemp plant, not a final law
Global

EU Council adopts negotiating position covering the whole hemp plant, not a final law

The EU Council adopted a partial negotiating position covering all hemp parts, with a 0.3% delta-9 THC threshold and national safeguards. Negotiations and final agreement remain. It does not legalize every finished hemp product throughout the EU.

2026-10-29

Quebec survey: past-year cannabis use falls to about 14%; 72% of users obtain some from SQDC
Global

Quebec survey: past-year cannabis use falls to about 14%; 72% of users obtain some from SQDC

Quebec's survey found past-year use among residents aged 15 and older fell to about 14% from about 17%. Some 72% of users obtained at least some cannabis from SQDC, not exclusively or as a market-share measure. Descriptive age-varying results do not establish legalization as the cause.

2026-10-28

Morocco's Sothema Receives Three Cannabis-Based Epilepsy Drug Authorizations
Global

Morocco's Sothema Receives Three Cannabis-Based Epilepsy Drug Authorizations

Sothema reportedly received marketing authorizations for three cannabis-based epilepsy medicines. Final distribution requirements remained and names, exact formulations, prices and launch dates were undisclosed. This is a regulatory milestone, not immediate pharmacy availability or new efficacy evidence.

2026-10-19

Morocco’s ANRAC revokes 1,490 legal cannabis licences for regulatory non-compliance
Global

Morocco’s ANRAC revokes 1,490 legal cannabis licences for regulatory non-compliance

ANRAC revoked 1,490 licences for non-compliance, including about 1,300 farming and 190 other supply-chain licences, according to Hespress. This is compliance enforcement within legal production, not a blanket industry ban or recreational legalization.

2026-10-15

Aurora urges shareholders to reject Curaleaf’s revised bid while exploring alternatives
Global

Aurora urges shareholders to reject Curaleaf’s revised bid while exploring alternatives

Aurora reiterated rejection of Curaleaf's revised offer and said multiple parties signed confidentiality and standstill agreements for strategic review. Undervaluation is Aurora's position, not an independently established value. No alternative transaction or acquisition completion is guaranteed.

2026-10-14

Bedrocan’s Dutch Entities Declared Bankrupt, Leaving Bedrolite Stock Transfers and Supply Uncertain
Global

Bedrocan’s Dutch Entities Declared Bankrupt, Leaving Bedrolite Stock Transfers and Supply Uncertain

Following September payment-suspension proceedings, two Dutch Bedrocan entities were declared bankrupt on October 7. Denmark entered separate restructuring. Bedrolite stock transfers require approval, creating continuity concerns for some patients, but projected supply gaps are not confirmed interruptions for everyone or bankruptcy of every group operation.

2026-10-07

NSW Passes Conditional THC Driving Reforms for Medical Cannabis Patients; Rollout Planned for Late 2026–Early 2027
Global

NSW Passes Conditional THC Driving Reforms for Medical Cannabis Patients; Rollout Planned for Late 2026–Early 2027

NSW passed conditional reforms for prescribed medical cannabis drivers requiring registration, prescription evidence and education. A 24-hour ban after a positive roadside test and impaired-driving penalties remain. Rollout is planned for late 2026 or early 2027, not immediate unrestricted driving permission.

2026-09-26

Thai Cabinet Approves Medical-and-Research Cannabis Bill, Not Yet an Enacted Law
Global

Thai Cabinet Approves Medical-and-Research Cannabis Bill, Not Yet an Enacted Law

Thailand's cabinet approved a medical-and-research cannabis bill proposing three-year licences and restrictions on consumption promotion. Cabinet approval is not parliamentary passage or enactment. The bill is separate from earlier ministerial licensing rules.

2026-09-22

UK FSA proposes authorisation of three CBD novel foods, with ministers to decide
Global

UK FSA proposes authorisation of three CBD novel foods, with ministers to decide

FSA proposed recommending ministerial authorisation of three high-purity CBD novel foods linked to about 3,000 products. Board agreement and ministerial decisions were pending at reporting. A UK–EU SPS agreement could supersede domestic authorisations without a CBD exception.

2026-09-10

1 / 6